Scientific Program

Date:
Saturday, December 2, 2017
ure
8.25
Introduction
Farhad Hafezi (Switzerland)
Basics
Chairs:
John Marshall / Sabine Kling
Rapid Fire
8.30
Structural differences of the collagen fibrils (CFs) and proteoglycans (PGs) between the peripheral and central part of the keratoconus cornea (KC)
S. Akhtar (KSA)
8.35
An investigation of the effects of riboflavin concentration on the efficacy of corneal cross-linking using an enzymatic resistance model in porcine corneas"
D. O'Brart (UK)
8.40
A New Tomographic Matrix for Early Detection of Keratoconus
M. Sinjab (KSA)
8.45
Discussion
8.50
In vivo Brillouin frequency shifts of crosslinked and uncrosslinked corneas in keratoconus
T. G. Seiler (Switzerland)
8.55
Laser Induced Ionization Field Crosslinks Biological Media in Absence of Photosensitizers
S. Vukelic (USA)
9.00
Non-contact technique for direct corneal strength measurement
D. Chernyak (USA)
9.05
Discussion
9.10
Riboflavin concentration during crosslinking at the endothelial level
T. G. Seiler (Switzerland)
9.15
The role of oxygen in corneal cross-linking (CXL) reactions
G. Lytle (USA)
9.20
Optimizing Genipin concentration for corneal collagen cross linking: An ex-vivo model
J. Alio (Spain)
9.25
Discussion
9.30
Predicting cross-linking outcomes and infiltrates using molecular biomarkers – implications for point of care diagnostics
N. Pahuja (India)
9.35
Carbon Nanostructures for ocular tissue reinforcement
A. Vega
CXL for ectasia
Chairs:
John A. Kanellopoulos / Farhad Hafezi
Rapid Fire
9.45
Ectasia: Causes and CXL (Cures)?
J. Marshall (UK)
9.55
Reproducibility and repeatability of corneal OCT cross-linking demarcation line measurement by human operators compared to a novel automated detection software"
S. Awwad (Lebanon)
10.00
Hormonal effect on progression of corneal ectasia – case reports
M. Vesela (Czech Republic)
10.05
Discussion
10.10-10.40
Coffee Break
10.40
High dose dietary riboflavin and sunlight treatment of keratoconus and ectasia - preliminary results
J. Jarstadt (USA)
10.45
Evaluating Efficacy in Varying Protocols of Customized Crosslinking (CXL)
R. Rajpal (USA)
10.50
Update on successful corneal crosslinking without epithelial removal
D. Stulting (USA)
10.55
Discussion
11.00
Safe CXL of thin corneas: light attenuation (RF/UVA) versus limited photosensitizer penetration (WST-D/NIR) protecting the endothelium in corneas below 400µm
J. Brekelmans (Netherlands)
11.05
How effective is crosslinking in keratoconus? A Malaysian study of 60 cases
Jenny P. Deva (Malaysia)
11.10
Prolonged Iontophoresis-assisted Transepithelial Corneal Cross-linking for Pediatric Keratoconus: Three Years Results"
Z. Lin (China)
11.15
Discussion
11.30-12.30
Lunch
12.30
Long-term follow-up on pediatric keratoconus
Cosimo Mazzotta (Italy)
12.40
A new biomechanical index for keratoconus
Paolo Vinciguerra (Italy)
12.50
CXL in ultrathin corneas, new algorithm
Farhad Hafezi (Switzerland)
13.00
Discussion
13.15
Customized Cross-Linking for keratoconus
Theo Seiler (Switzerland)
13.25
Molecular biomarkers & its future therapeutic potential in crosslinking
Rohit Shetty (India)
13.35
Oxygen diffusion limits the effectiveness of iontophoresis-assisted epi-on CXL
Emilio Torres (Switzerland
13.45
Discussion
PACK-CXL for infection
Chairs:
Guoyung Mu / Shihao Chen
Rapid Fire
14.00
Inhibitory effect of photodynamic antimicrobial therapy (PDAT) on healthcare- and community-acquired methicillin resistant Staphylococcus aureus (MRSA) isolates of ocular origin"
H. Durkee (USA)
14.05
The Therapeutic Effect of Accelerated Photoactivated Chromophore Corneal Cross-linking (PACK-CXL) compare to the standard antibiotic therapy in Infectious Keratitis.
B. Knaizer (Israel)
14.10
Assessment of UV-A/riboflavin corneal cross-linking efficacy for the treatment of experimentally induced corneal lesions in an ex vivo animal model
A. Perazzi (Italy)
14.15
Discussion
14.25
Blue-light activation of riboflavin for possible use in PACK-CXL
K. Makdoumi (Sweden)
14.30
TBD
Guoying Mu (China)
14.40
Quantifying the antimicrobial efficacy of PACK-CXL for different bacterial strains as a function of UV fluence and irradiated volume
S. Kling (Switzerland)
14.50
Discussion
15.05-15.45
Photo Shoot & Coffee Break
CXL in refractive surgery
Chairs:
Mazen Sinjab / David O’Brart
Rapid Fire
15.45
Biomechanical analysis of different re-treatment options after SmILE refractive surgery
B. Spiru (Germany)
15.50
Topo-guided removal of epithelium in keratoconus eyes (TREK): A novel tissue saving customised ablation strategy.
P. Khamar (India)
15.55
CXL+ is it safe?
J. Frucht-Pery (Israel)
16.00
Discussion
16.10
Phototherapeutic intrastromal corneal collagen cross-linking (PiXL) with two different UV irradiation protocols for treatment of low-grade myopia
A. Fredriksson (Sweden)
16.15
Topography and pachymetry guided customised tissue saving epithelial ablation in cross-linking of thin cornea : the SAVE protocol
A. Bajaj (India)
16.20
Brillouin microscopy for LASIK Xtra
J. Bradley Randleman (USA)
16.30
TBD
John Marshall (UK)
16.40
Discussion
Hot Topics
16.50 - 17.15
Is epi-on established?
Yes: Doyle Stulting (5')
No: David O'Brart (5')
Panel discussion (15’)
Panel: Hafezi, Chen, Seiler
17.20 - 17.45
Does Cross-linking as a refractive stand-alone procedure work?
Yes: Matthias Elling (5')
No: Theo Seiler (5')
Panel discussion (15')"
Panel: Sinjab, Torres, Spoerl
17.50 - 18.15
Does LASIK Xtra work?
Yes: John Kanellopoulos (5')
No: Brad Randleman (5')
Panel discussion (15')"
Panel: Vinciguerra, Awwad
18.20 - 18.30
Theo Seiler Award
Scientific Committee
 
Poster Prize
Scientific Committee
 
Final Remarks, CXL Experts Meeting 2018 announcement
Farhad Hafezi

Pin It on Pinterest